Page 15 - Read Online
P. 15

Shannon et al. Mini-invasive Surg 2023;7:32  https://dx.doi.org/10.20517/2574-1225.2023.83  Page 9 of 15

               Table 2. Ongoing clinical comparing minimally invasive and open pancreaticoduodenectomy
                            Year      Anticipated
                Trial name                           Groups          Patient population   Primary end point
                            registered  completion date
                NCT04211948  2019     2024           Robotic PD vs. OPD  PDAC             1 and 3-year OS
                MIOP-       2018      2028           MIPD vs. OPD    Resectable PDAC, bile duct,   30-day complications
                NCT03747588                                          ampullary cancer
                PORTAL      2020      2022           Robotic PD vs. OPD  Resectable PDAC,   Time to functional
                NCT04400357                                          periampullary cancer  recovery
                NCT04171440  2020     2024           Robotic PD      Benign + malignant pancreas or  Hospital LOS
                                                                     periampullary lesion
                NCT03785743  2019     2027           Laparoscopic PD vs.   PDAC           5-year OS
                                                     OPD
                NCT03138213  2018     2022           Laparoscopic PD vs.   Periampullary cancer  LOS
                                                     OPD
                DIPLOMA-2   2022      2026           Robotic or      Premalignant or malignant   Safety and time to
                ISRCTN27483786                       laparoscopic PD vs.  disease         functional recovery
                                                     OPD

               LOS: Length of stay; MIPD: minimally invasive pancreaticoduodenectomy; OPD: open pancreaticoduodenectomy; OS: overall survival; PD:
               pancreaticoduodenectomy; PDAC: pancreatic ductal adenocarcinoma.

               20-25 cases, whereas a separate study showed improved operative times and performance in 30 cases [102,103] .
               One study found the number of cases needed to achieve proficiency in robotic PD was 40 . While the
                                                                                              [104]
               “exact” number of cases needed to achieve proficiency is heavily dependent on a number of factors (surgeon
               training, surgeon experience, operating room staff, etc.), intensive training programs focused on minimally
               invasive techniques are crucial to overcome this learning curve [105-107] .


               The extensive learning curve in minimally invasive pancreas surgery is due in part to the complexity of the
               reconstruction. Methods of reconstruction and management of the pancreatic stump during minimally
               invasive PD and DP, respectively, are crucial to reducing post-operative complications. Complications of
               minimally invasive pancreas surgery are similar to those encountered in open approaches, namely
               pancreatic leak or fistula, postpancreatectomy hemorrhage, anastomotic leak, bile leak, delayed gastric
               emptying, and pancreatogenic diabetes. Yet, as discussed in the sections above, there is no convincing data
               showing increased rates of complications or the need for further procedures to treat complications due to a
               minimally invasive approach.


               The actual approach for minimally invasive pancreatectomy can be executed in several ways, including total
               laparoscopic or robotic alone, a hybrid approach where the robot is docked but in conjunction with a
               bedside assistant using laparoscopic instruments, or a hand-assisted approach. The superiority of these
               different techniques remains debatable and should depend on surgeon comfort and experience and various
               patient factors such as body mass, pancreatic duct size, and firmness of the gland. As such, there has been
               no definitive evidence to indicate a difference in pancreatic leak rate between any of these approaches [108,109] .
               Minimally invasive DP has similar morbidity compared to open approaches, with the advantages of quicker
               return to functional baseline, shorter hospital stay, and improved cosmetics. However, given the complexity
               of reconstruction, the advantages of minimally invasive PD are fewer. Nevertheless, as the robotic platform
               becomes more universally adopted and more commonly used, the technical acumen of surgeons to perform
               this complex surgery will increase, potentially leading to improved outcomes in the future for carefully
               selected patients.
   10   11   12   13   14   15   16   17   18   19   20